NeuroScientific Biopharmaceuticals: Secures $3.7m tax incentive refund

NeuroScientific Biopharmaceuticals Secures $3.7m tax incentive refund

• NeuroScientific Biopharmaceuticals (NSB) pockets a $3.7 million tax refund from the Australian Federal Government.
• The company received the government incentive payment for research and development undertaken during the 2021/2022 financial year
• The government incentive program offers cash refunds for up to 43.5 per cent of eligible expenditure on research and development
• NSB says the refund will be reinvested into its preclinical and clinical research programs currently being undertaken to support the commercialisation of its lead drug candidate, EmtinB
• NeuroScientificBiopharmaceuticals is up 1.02 per cent and trading at 9.9 cents at 3:29 pm AEDT